Masaru Yoshioka , Walter G. Bradley , Paul Shapshak , Isao Nagano , Rene V. Stewart , Ke-Qin Xin , Ashok K. Srivastava , Shozo Nakamura
{"title":"Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases","authors":"Masaru Yoshioka , Walter G. Bradley , Paul Shapshak , Isao Nagano , Rene V. Stewart , Ke-Qin Xin , Ashok K. Srivastava , Shozo Nakamura","doi":"10.1016/0960-5428(95)00012-Q","DOIUrl":null,"url":null,"abstract":"<div><p>Central nervous system (CNS) involvement is common during human immunodeficiency virus type-1 (HIV-1) infection. The neurologic disease of the CNS most frequently observed during acquired immunodeficiency syndrome (AIDS) is HIV-1-associated cognitive/motor complex or AIDS dementia complex (ADC), which is most likely a direct consequence of HIV-1 infection of the CNS. The peripheral nervous system (PNS) is also affected in HIV-1-infected individuals and there are several features of immune- and cytokine-related pathogenesis in both the CNS and PNS that are reviewed.</p><p>Several lines of evidence demonstrate aspects of immune activation in the CNS and peripheral nervous system (PNS) of HIV-1-infected individuals. The relative paucity of HIV-1 expression in contrast to widespread functional and pathologic changes in the CNS and PNS of AIDS patients, and the lack of evidence of productive infection of HIV-1 in neuronal cells <em>in vivo</em> lead to the possibility of indirect or immunopathogenic mechanisms for HIV-1-related neurologic diseases.</p><p>Proposed mechanisms of neuronal and glial cell damage are injury of oligodendrocytes by tumor necrosis factor-α (TNF-α) released from activated macrophage/microglia, calcium-dependent excitoneuro-toxicity induced by gp120 HIV-1 envelope protein, <em>N</em>-methyl-<span>d</span>-aspartate (NMDA) receptor-mediated neurotoxicity by quinolinic acid (a product of activated macrophages), cell injury by HIV-1-specific cytotoxic T cells, and apoptosis of oligodendrocytes or neurons triggered by interaction between cell surface receptors and HIV-1 gp120 protein.</p><p>Common to those mechanisms is the dependence on cellular activation with expression of proinflammatory cytokines (TNF-α, interleukin-1). Amplification of activation signals through the cytokine network by macrophage/astrocyte/endothelial cell interactions, and cell-to-cell contact between activated macrophages and neural cells by upregulation of adhesion molecules dramatically enhances the toxic effect of macrophage products.</p><p>Expression of immunosuppressive cytokines such as interleukin-4, interleukin-6, and transforming growth factor-β is also increased in the CNS and PNS of HIV-1-infected patients. This may serve as neuroprotective and regenerative mechanism against insults to nervous system tissue.</p></div>","PeriodicalId":79314,"journal":{"name":"Advances in neuroimmunology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1995-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0960-5428(95)00012-Q","citationCount":"77","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in neuroimmunology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/096054289500012Q","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 77
Abstract
Central nervous system (CNS) involvement is common during human immunodeficiency virus type-1 (HIV-1) infection. The neurologic disease of the CNS most frequently observed during acquired immunodeficiency syndrome (AIDS) is HIV-1-associated cognitive/motor complex or AIDS dementia complex (ADC), which is most likely a direct consequence of HIV-1 infection of the CNS. The peripheral nervous system (PNS) is also affected in HIV-1-infected individuals and there are several features of immune- and cytokine-related pathogenesis in both the CNS and PNS that are reviewed.
Several lines of evidence demonstrate aspects of immune activation in the CNS and peripheral nervous system (PNS) of HIV-1-infected individuals. The relative paucity of HIV-1 expression in contrast to widespread functional and pathologic changes in the CNS and PNS of AIDS patients, and the lack of evidence of productive infection of HIV-1 in neuronal cells in vivo lead to the possibility of indirect or immunopathogenic mechanisms for HIV-1-related neurologic diseases.
Proposed mechanisms of neuronal and glial cell damage are injury of oligodendrocytes by tumor necrosis factor-α (TNF-α) released from activated macrophage/microglia, calcium-dependent excitoneuro-toxicity induced by gp120 HIV-1 envelope protein, N-methyl-d-aspartate (NMDA) receptor-mediated neurotoxicity by quinolinic acid (a product of activated macrophages), cell injury by HIV-1-specific cytotoxic T cells, and apoptosis of oligodendrocytes or neurons triggered by interaction between cell surface receptors and HIV-1 gp120 protein.
Common to those mechanisms is the dependence on cellular activation with expression of proinflammatory cytokines (TNF-α, interleukin-1). Amplification of activation signals through the cytokine network by macrophage/astrocyte/endothelial cell interactions, and cell-to-cell contact between activated macrophages and neural cells by upregulation of adhesion molecules dramatically enhances the toxic effect of macrophage products.
Expression of immunosuppressive cytokines such as interleukin-4, interleukin-6, and transforming growth factor-β is also increased in the CNS and PNS of HIV-1-infected patients. This may serve as neuroprotective and regenerative mechanism against insults to nervous system tissue.